Profile
Christopher Seiter worked as the Chief Financial Officer at Trevi Therapeutics, Inc. from 2018 to 2021.
Prior to that, he held the same position at Millendo Therapeutics, Inc. He also worked as MD & Head-Life Sciences Investment Banking at Bank of America Merrill Lynch (New York).
Seiter completed his undergraduate degree at the University of Rochester.
Former positions of Christopher Seiter
| Companies | Position | End |
|---|---|---|
| TREVI THERAPEUTICS, INC. | Director of Finance/CFO | 2021-04-01 |
| Bank of America Merrill Lynch (New York) | Corporate Officer/Principal | - |
| MILLENDO THERAPEUTICS | Director of Finance/CFO | - |
Training of Christopher Seiter
| Rochester Christian University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| TREVI THERAPEUTICS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
| Bank of America Merrill Lynch (New York) | |
Millendo Therapeutics, Inc.
 Millendo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Millendo Therapeutics, Inc. is a biopharmaceutical company, which engages in seeking distinct and transformative treatments where there is a significant unmet medical need. The company was founded by Julia C. Owens in January 2012 and is headquartered in Ann Arbor, MI. | Health Technology |
- Stock Market
- Insiders
- Christopher Seiter
